Clinical Trials Related to Bladder Cancer

Related studies linked through entity extraction aliases.

Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer

Status: TERMINATED
Phase: PHASE1/PHASE2

A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

Status: COMPLETED
Phase: PHASE3

Durvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients (DUTRENEO)

Status: COMPLETED
Phase: PHASE2

Intracorporeal vs Extracorporeal Urinary Diversion After Robot Assisted Radical Cystectomy

Status: COMPLETED
Phase: NA

A Study of BCD-135 in Patients With Advanced Solid Tumors

Status: UNKNOWN
Phase: PHASE1

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

Status: COMPLETED
Phase: PHASE1

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Status: RECRUITING
Phase: N/A

Open Versus Robot Assisted Radical Cystectomy With Totally Intracorporeal Urinary Diversion.

Status: COMPLETED
Phase: NA

Assessment of BladderLight SurvEILlance

Status: UNKNOWN
Phase: PHASE2/PHASE3

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Status: RECRUITING
Phase: N/A

A Study Using MRI To Assess Bladder Motion During Radiotherapy

Status: UNKNOWN
Phase: NA

Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Status: TERMINATED
Phase: PHASE2

Endo-GIA Versus Endowrist Stapler in Intracorporeal Urinary Diversion in Robotic Assisted Radical Cystectomy

Status: COMPLETED
Phase: NA

Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer

Status: RECRUITING
Phase: PHASE2

SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly

Status: RECRUITING
Phase: NA

Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC

Status: COMPLETED
Phase: PHASE4

Trimodal Prehabilitation for Cystectomy Patients to Enhance Post-operative Care

Status: UNKNOWN
Phase: NA

Project HERO: Health Empowerment & Recovery Outcomes

Status: COMPLETED
Phase: NA

Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.

Status: TERMINATED
Phase: PHASE3